Literature DB >> 10198471

Verocytotoxin-producing Escherichia coli O157: public health and microbiological significance.

F J Bolton1, H Aird.   

Abstract

Escherichia coli O157 was recognised as a human pathogen in the late 1970s, its public health significance being recognised in 1982 when it was implicated in a large outbreak of infection associated with a fast-food restaurant in North America. Incidence of infection in the population is relatively low compared to other enteric pathogens; however, this organism causes a spectrum of disease increasing in severity from a mild diarrhoeal illness to haemorrhagic colitis, haemolytic uraemic syndrome (HUS) and, in some cases, death. Production of verocytotoxin and intimin, and the presence of a 60 mDa plasmid are thought to be important virulence factors; however, many currently unidentified factors may also contribute. The infectious dose of this organism is low and reports of food-borne, water-borne and person-to-person transmission have occurred, including several laboratory-acquired infections. Techniques for isolation, identification and confirmation of these organisms, based on cultural, immunological and molecular detection, are described. Additionally, schemes have been developed to type these organisms for epidemiological investigation, and the roles of phage typing and genotyping are discussed. These enable identification of sources and the introduction of intervention strategies for prevention of spread in the community.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10198471

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  2 in total

1.  An immunodiagnostic method for the detection of Shiga-like toxigenic Escherichia coli in faeces.

Authors:  N J Asha; D M Gascoyne-Binzi; P M Hawkey
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Genetic characteristics of Shiga toxin-producing E. coli O157, O26, O103, O111 and O145 isolates from humans, food, and cattle in Belgium.

Authors:  K Verstraete; K DE Reu; S VAN Weyenberg; D Piérard; L DE Zutter; L Herman; J Robyn; M Heyndrickx
Journal:  Epidemiol Infect       Date:  2013-02-28       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.